Liu Y - Search Results

1

The role of metabolic reprogramming in pancreatic cancer chemoresistance.

Liu C, Li C, Liu Y. Liu C, et al. Among authors: liu y. Front Pharmacol. 2023 Jan 9;13:1108776. doi: 10.3389/fphar.2022.1108776. eCollection 2022. Front Pharmacol. 2023. PMID: 36699061 Free PMC article. Review.

2

Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.

Liu Y, Zhang Z, Wang J, Chen C, Tang X, Zhu J, Liu J. Liu Y, et al. Among authors: liu j. Onco Targets Ther. 2019 Feb 13;12:1195-1204. doi: 10.2147/OTT.S189687. eCollection 2019. Onco Targets Ther. 2019. PMID: 30863087 Free PMC article. Review.

3

Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer.

Liu Y, Li C, Lu Y, Liu C, Yang W. Liu Y, et al. Among authors: liu c. Front Immunol. 2022 Oct 20;13:1016817. doi: 10.3389/fimmu.2022.1016817. eCollection 2022. Front Immunol. 2022. PMID: 36341377 Free PMC article. Review.

4

The role of metal ions in the occurrence, progression, drug resistance, and biological characteristics of gastric cancer.

Xiao P, Li C, Liu Y, Gao Y, Liang X, Liu C, Yang W. Xiao P, et al. Among authors: liu y, liu c. Front Pharmacol. 2024 Feb 2;15:1333543. doi: 10.3389/fphar.2024.1333543. eCollection 2024. Front Pharmacol. 2024. PMID: 38370477 Free PMC article. Review.

5

Kynureninase induce cuproptosis resistance in gastric cancer progression through downregulating lipotic acid synthetase mediated non-canonical mechanism.

Liu Y, Li C, Cui X, Liu C, Xiao P, Yang W. Liu Y, et al. Among authors: liu c. Cell Signal. 2025 Mar;127:111565. doi: 10.1016/j.cellsig.2024.111565. Epub 2024 Dec 14. Cell Signal. 2025. PMID: 39681223

6

AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer.

Li C, Liu Y, Liu C, Chen F, Xie Y, Zeh HJ, Yu C, Liu J, Tang D, Kang R. Li C, et al. Among authors: liu j, liu y, liu c. Sci Transl Med. 2025 Jan 29;17(783):eadp4986. doi: 10.1126/scitranslmed.adp4986. Epub 2025 Jan 29. Sci Transl Med. 2025. PMID: 39879317

7

Potential therapeutic targets for colorectal cancer and its subsites: evidence from the proteome-wide Mendelian randomization analyses.

Li J, Liu Y, Liu C, Xiao P. Li J, et al. Among authors: liu y, liu c. Transl Cancer Res. 2025 Jan 31;14(1):486-496. doi: 10.21037/tcr-24-1503. Epub 2025 Jan 20. Transl Cancer Res. 2025. PMID: 39974404 Free PMC article.

8

Causal association between type 1 diabetes and autoimmune cholestasis: A bi-directional Mendelian randomized study.

Liu Y, Chen L, Hao W, Zhao K, Li C. Liu Y, et al. Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251327621. doi: 10.1177/03946320251327621. Epub 2025 Apr 11. Int J Immunopathol Pharmacol. 2025. PMID: 40216386 Free PMC article.

9

Gut microbiota - bidirectional modulator: role in inflammatory bowel disease and colorectal cancer.

Cui X, Li C, Zhong J, Liu Y, Xiao P, Liu C, Zhao M, Yang W. Cui X, et al. Among authors: liu y, liu c. Front Immunol. 2025 Apr 30;16:1523584. doi: 10.3389/fimmu.2025.1523584. eCollection 2025. Front Immunol. 2025. PMID: 40370465 Free PMC article. Review.

10

B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway.

Xiao PT, Li CF, Liu YD, Zhong J, Cui XL, Liu C, Yang W. Xiao PT, et al. World J Gastroenterol. 2025 Sep 14;31(34):109825. doi: 10.3748/wjg.v31.i34.109825. World J Gastroenterol. 2025. PMID: 40937457 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234,562 results

Search Page

Filters